Q1 2021 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst First Quarter 2021 Earnings Call. Please note that today's call is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker for today, John Bluth at BioCryst. John, the floor is yours.
Thanks, Jay. Good morning and welcome to BioCryst's First Quarter 2021 Corporate Update and Financial Results Conference Call. Today's press release is available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief R&D Officer, Dr. Helen Thackray. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |